Advertorial LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" Hand-out Oct 13, 2025 Oct 13, 2025 Updated Oct 14, 2025 Facebook Twitter WhatsApp SMS Email Print Copy article link Save Eisai logo and Biogen logo (PRNewsfoto/Eisai Co., Ltd.) Hand-out As featured on Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease New LEQEMBI CompanionTM program launched to expand helpful resources for patients throughou… LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" TOKYO and CAMBRIDGE, Mass., Oct. 13, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tok… Facebook Twitter WhatsApp SMS Email Print Copy article link Save Sections AutomotiveBridalBusiness And CareersCommunity CaresEducationEspanolFamily LivingFashion, Beauty & FitnessFood, Recipes & EntertainingGift IdeasGreen LivingHealth & WellnessHome DecoratingHome ImprovementHot TopicsHow ToKitchen, Bed & BathLawn & GardenMoney & FinancePetsPress ReleasesReal EstateSeasonalSenior LivingSportsTech Talk & InnovationTravel Trending Now DSN Week 6 Power Rankings Highlights: James M. Bennett Hands Stephen Decatur Boys Soccer Their First Loss This Season Highlights: Stephen Decatur Defeats James M. Bennett Girls Soccer 1-0 in Double Overtime Thriller Highlights: Salesianum and Caesar Rodney Draw 1-1 Highlights: Smyrna defeats Cape Henlopen 42-34 in the Last Two Minutes for Football Friday
Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease New LEQEMBI CompanionTM program launched to expand helpful resources for patients throughou…
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" TOKYO and CAMBRIDGE, Mass., Oct. 13, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tok…
